Viewing Study NCT06512454



Ignite Creation Date: 2024-10-26 @ 3:35 PM
Last Modification Date: 2024-10-26 @ 3:35 PM
Study NCT ID: NCT06512454
Status: RECRUITING
Last Update Posted: None
First Post: 2024-07-16

Brief Title: A Study in Adults to Learn About Inherited Alpha-1 Antitrypsin Deficiency AATD and AATD Related Liver Problems
Sponsor: None
Organization: None

Study Overview

Official Title: Prospective Observational Study on the Natural History of Alpha-1 Antitrypsin Deficiency and Associated Liver Disease
Status: RECRUITING
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The main aim of this study is to learn about liver problems caused by the lack of alpha-1 antitrypsin called Alpha-1 Antitrypsin Deficiency or AATD in adults when not treated this is called the natural history of a condition over 5 years Other aims are to learn what can predict the AATD-liver condition starting and getting better or worse describe how this condition is currently being diagnosed and watched in normal hospital care and describe how the AATD also affects and adults lung function

Data in this study will be collected to include medical history of a participant including the date AATD was first identified andor the date on which the first AATD-related liver or lung problems were diagnosed At study start and then every year until study end participants will be asked to completed questionnaires called patient-reported outcomes or PRO
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None